Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
509.00    -13.00 (-2.49%)
Bid:
509.00
Ask:
511.00
Spread: 2.00 (0.393%)
Market Cap: £499.86m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

7 Nov 2018 13:00

RNS Number : 6607G
Galliford Try PLC
07 November 2018
 

7 November 2018

 

Galliford Try plc

 

Update on Aberdeen Western Peripheral Route and Current Trading

Galliford Try plc ("Galliford Try" or the "Group"), the housebuilding, regeneration and construction group today issues an update on the Aberdeen Western Peripheral Route ("AWPR") contract and Group trading. This statement covers the period 1 July 2018 to 7 November 2018.

 

On AWPR, the completion date for the final section, including the bridge over the River Don, is now expected to be in December owing to increased complexity and weather delays in implementing repairs to the bridge. As a result of higher than anticipated direct costs, and the further delay to completion, our estimate of the final costs to complete the contract has increased by approximately £20m. The final impact on the Galliford Try's financial results will be determined more importantly by the result of the Group's significant claim, in respect of which the Board continues to pursue constructive discussions with the client.

 

The underlying Construction business continues to trade in line with expectations.

 

Linden Homes continues to make good progress against its strategic targets. Sales rates are lower than levels achieved in FY 2018, but prices and margins remain in line with expectations and the business expects to achieve its targets for the full year.

 

Partnerships & Regeneration is trading strongly in both mixed-tenure and contracting, with continuing strong demand across all regions, backed by resolute political support for this sector.

 

The Group expects to report a FY 2019 pre-exceptional profit before tax in line with previous guidance. Average net debt for FY 2019 is expected to remain in the previously guided range of £170m to £190m before any recoveries in relation to the AWPR contract.

 

This announcement contains inside information.

 

For further enquiries please contact:

 

Galliford Try

Peter Truscott, Chief Executive 01895 855001

Graham Prothero, Finance Director

 

Tulchan Communications

James Macey White 020 7353 4200

Martin Pengelley

Elizabeth Snow

 

Notice of results

 

Galliford Try will hold its Annual General Meeting at 10:30 am on Friday 9 November 2018 at the offices of CMS Cameron McKenna Nabarro Olswang LLP, Cannon Place, 78 Cannon Street, London, EC4N 6AF.

 

Galliford Try expects to announce its interim results for the six months to 31 December 2018 on 13 February 2019.

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Notes to editors

 

Galliford Try is listed on the London Stock Exchange and is a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure projects with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2018, the Group generated revenue of £3.1 billion.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSFLFLDIIT
Date   Source Headline
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20224:00 pmRNSAnnual Financial Report
7th Oct 20224:00 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20227:00 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20225:30 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20225:03 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20224:45 pmRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20223:00 pmRNSEmployee Share Trust Trading Plan
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:01 amRNSLaunch of Share Buyback Programme
21st Sep 20227:00 amRNSFinal Results
1st Aug 20227:00 amRNSContract
14th Jul 20227:00 amRNSTrading Statement
11th Jul 20227:00 amRNSAcquisition of MCS Control Systems
1st Jul 202211:00 amRNSDirector Declaration
23rd Jun 20227:00 amRNSContract
31st May 20227:00 amRNSTotal Voting Rights
30th May 202210:00 amRNSExercise of share options
10th May 20227:00 amRNSBusiness Briefing
26th Apr 20227:00 amRNSAppointment of Director
1st Apr 20229:10 amRNSConfirmation of Directorate Change
15th Mar 20227:00 amRNSDirectorate Change
4th Mar 20225:03 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSHalf-year Results
9th Feb 20227:00 amRNSContract
19th Jan 20227:00 amRNSTrading Update
31st Dec 202112:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 202111:51 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSContract
12th Nov 20214:01 pmRNSResult of AGM
12th Nov 20217:00 amRNSAGM Statement
7th Oct 20213:23 pmRNSAcquisition
7th Oct 202110:27 amRNSDirector Declaration
6th Oct 20217:00 amRNSContract
5th Oct 20214:47 pmRNSAnnual Financial Report
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
17th Sep 20211:00 pmRNSEmployee Share Trust Trading Plan
16th Sep 20217:00 amRNSFinal Results
26th Aug 20213:42 pmRNSHolding(s) in Company
16th Aug 202110:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.